stock.name

Cytokinetics Inc

CYTK

Market Cap$6.8B
Close$

Compare Cytokinetics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cytokinetics IncCytokinetics Inc-12.90%136%--1.6
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$68.82

Current Fair Value

3.6% downside

Overvalued by 3.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.80 Billion
Enterprise Value$6.80 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-5.45
Beta1.35
Outstanding Shares103,004,710
Avg 30 Day Volume3,115,570

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-12.92
PEG3668.5
Price to Sales-
Price to Book Ratio-17.85
Enterprise Value to Revenue903.59
Enterprise Value to EBIT-13.71
Enterprise Value to Net Income-13
Total Debt to Enterprise0.09
Debt to Equity-1.6

Revenue Sources

No data

ESG Score

No data

About Cytokinetics Inc

CEO: Robert Blum